🇺🇸 FDA
Patent

US 8337854

Monoclonal antibodies against dengue and other viruses with deletion in Fc region

granted A61KA61K2039/505A61P

Quick answer

US patent 8337854 (Monoclonal antibodies against dengue and other viruses with deletion in Fc region) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/505, A61P, A61P31/12, A61P31/14